Petrelintide dose guide

A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.

Petrelintide dosage

A once-weekly amylin drug from Zealand Pharma and Roche, a long-acting copy of the fullness hormone the pancreas releases with insulin. In its 42-week phase 2 trial, people lost about 8% to 10% of their weight at 28 weeks and up to about 10.7% by week 42, less than GLP-1 drugs but with GI side effects close to placebo apart from mild nausea. Commonly reported: feeling full sooner and smaller portions. It is in phase 3 and not approved anywhere.

Dose range
1–9 mg (research range). Trials and labels start at 0.6 mg and step up. Studied in research — not a recommendation.
How often
Weekly
A typical run
Ongoing. Used continuously, once weekly, in its trials: 42 weeks in ZUPREME-1 and 28 weeks in ZUPREME-2, with steps every 4 weeks. No trial has tested stopping it.
How it’s taken
Vial: SubQ injection
Evidence
Moderate: Animal studies + some human data
Half-life
~10 days (measured in people: mean 213–257 h after SubQ doses, 239 h IV; Brændholt Olsen 2026)

Petrelintide on your syringe

With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 1 mg, is 20 units; and the high end, 9 mg, needs a stronger mix than one syringe holds. 10 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

Track the doses you run

PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.

Get PepVault on the App Store7 days free on the yearly plan for new subscribers.

More glp-1 & metabolic peptides

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.